GENOTYPE-RESPONSE CORRELATION IN DRIVE PK, A PHASE 2 STUDY OF MITAPIVAT (AG-348) IN PATIENTS WITH PYRUVATE KINASE DEFICIENCY

EHA Library, Charles Kung, 266226

FOSTAMATINIB, A SPLEEN TYROSINE KINASE INHIBITOR, FOR THE TREATMENT OF WARM ANTIBODY AUTOIMMUNE HEMOLYTIC ANEMIA: INITIAL RESULTS OF THE OPEN-LABEL EXTENSION PERIOD OF THE SOAR PHASE 2 STUDY

EHA Library, David Kuter, 266227

GLUCOSYLSPHINGOSINE (LYSO-GL-1), A BIOMARKER OF GAUCHER DISEASE, CORRELATES WITH DISEASE SEVERITY AND RESPONSE TO ELIGLUSTAT IN 2 CLINICAL TRIALS OF TREATMENT-NAÏVE ADULTS WITH GAUCHER DISEASE TYPE 1

EHA Library, M. Judith Peterschmitt, 266228

MOLECULAR GENETIC STUDY OF ACUTE INTERMITTENT PORPHYRIA IN RUSSIA.

EHA Library, Maria Goncharova, 266229

EARLY POST-TRANSPLANTATION ANEMIA IS ASSOCIATED WITH MORTALITY OR GRAFT FAILURE IN LIVER TRANSPLANTED ADULTS

EHA Library, Tamar Berger, 266230

CLINICAL CHARACTERISTICS, TREATMENT PATTERNS, AND THROMBOEMBOLIC RISK OF PATIENTS WITH COLD AGGLUTININ DISEASE (CAD) IN JAPAN

EHA Library, Jun-ichi Nishimura, 266231

EPIDEMIOLOGICAL SHIFT OF GLUCOSE-6-PHOSPHATE DEHYDROGENASE (G6PD) MUTATIONS IN NORTHERN ITALY DURING THE LAST 15 YEARS

EHA Library, Giovanna Graziadei, 266232

SOLUBLE MANNOSE RECEPTOR IS A POTENTIAL NEW BIOMARKER FOR PLASMA CELL DYSCRASIAS AND OTHER SKELETAL COMPLICATIONS IN GAUCHER DISEASE

EHA Library, Brendan Beaton, 266233

GLUCOPHOSPHATE ISOMERASE DEFICIENCY IDENTIFIED BY NEXT-GENERATION SEQUENCING

EHA Library, Sona M Vora, 266234

A FLEXIBLE THERAPEUTIC STRATEGY FOR LEUKEMIA USING EX-VIVO EXPANDED T CELLS COMBINED WITH BISPECIFIC ANTIBODIES

EHA Library, Josee Golay, 266235

GMP MANUFACTURING OF ALLOGENEIC CD19 CHIMERIC ANTIGEN RECEPTOR (CAR) CYTOKINE INDUCED KILLER (CIK) CELLS WITH SLEEPING BEAUTY (SB) TRANSPOSON FOR ADOPTIVE IMMUNOTHERAPY

EHA Library, Giuseppe Gaipa, 266236

PLATINUM TALEN-MEDIATED NON-VIRAL T CELL RECEPTOR GENE KNOCK-IN FACILITATES UNIVERSAL T CELL GENOME EDITING FOR MANUFACTURING OF THERAPEUTIC IMMUNE CELLS

EHA Library, Yasuko Honjo, 266237

NKP30-BASED CHIMERIC ANTIGEN RECEPTOR REDIRECTED HUMAN T LYMPHOCYTES INDUCE EFFECTIVE ANTITUMORAL IMMUNE RESPONSES TO ACUTE MYELOID LEUKEMIA AND MELANOMA

EHA Library, Sophie Riedel, 266238

EXPLORING THE THERAPEUTIC POTENTIAL OF T-CELL-RECEPTOR REDIRECTED CD3+ NATURAL KILLER CELLS FOR ADOPTIVE CELLULAR THERAPY TO ACUTE MYELOID LEUKEMIA.

EHA Library, Jan Wernersbach, 266239

CAR T-CELL THERAPY: KNOWLEDGE GAPS AND EDUCATIONAL NEEDS FOR HEMATOLOGISTS/ONCOLOGISTS

EHA Library, Lauren Willis, 266240

RED BLOOD CELLS PROPERTIES IN PATIENTS WITH SICKLE CELL DISEASE TREATED WITH LENTIGLOBIN GENE THERAPY IN THE HGB-205 TRIAL

EHA Library, Elisa Magrin, 266241

TREATMENT WITH 5-AZACYTIDINE RESULTS IN EXPRESSION OF LONG TERMINAL REPEAT (LTR) ELEMENTS IN PERIPHERAL BLOOD MONONUCLEAR CELLS OF PATIENTS WITH MDS AND AML: FIRST PILOT STUDY.

EHA Library, Michael Daskalakis, 266242

ADOPTIVE IMMUNOTHERAPY OF INVASIVE ASPERGILLOSIS BY T CELLS VACCINES AGAINST ASPERGILLOSIS IN MOUSE MODEL

EHA Library, Haizhou Xing, 266243

IDENTIFICATION OF T-CELL RECEPTORS FROM THE ALLOGENEIC-HLA REPERTOIRE SPECIFIC FOR MELANOMA-ASSOCIATED ANTIGENS

EHA Library, Marije De Rooij, 266244

INHIBITION OF ACUTE LYMPHOBLASTIC AND MYELOID LEUKEMIAS BY NOVEL CHIMERIC MOUSE-HUMAN MONOCLONAL ANTIBODIES AGAINST ANTIGEN PRAME

EHA Library, Andrey Misyurin, 266245

EVALUATING EX VIVO EXPANSION OF FUNCTIONALLY COMPETENT MULTI-SPECIFIC T LYMPHOCYTES TO MINOR HISTOCOMPATIBILITY ANTIGEN FOR THE TREATMENT OF HEMATOLOGICAL MALIGNANCIES

EHA Library, Annabelle Minguy, 266246

IOVANCE PERIPHERAL BLOOD LYMPHOCYTES (PBL): A POTENTIAL CELL THERAPY STRATEGY FOR THE TREATMENT OF CHRONIC LYMPHOCYTIC LEUKEMIA

EHA Library, Lavakumar Karyampudi, 266247

EFFECTIVE STABILIZATION OF VIRAL VECTORS IN LIQUID USING AN ALGORITHM-BASED DEVELOPMENT APPROACH

EHA Library, Eva Reinauer, 266248

INACTIVATION OF THE NUCLEAR INTERACTING SET DOMAIN PROTEIN 1 IMPAIRS GATA1-REGULATED TERMINAL ERYTHROID MATURATION AND INDUCES ERYTHROLEUKEMIA

EHA Library, Marwa Almosailleakh, 266249

HIGH PLOIDY LARGE CYTOPLASMIC MEGAKARYOCYTES: KEY NEGATIVE REGULATORS OF HEMATOPOIETIC STEM CELLS AND ESSENTIAL FOR PLATELET PRODUCTION

EHA Library, Susie Nilsson, 266250

GLUCOCORTICOID INDUCED LEUCINE ZIPPER (GILZ) IS REQUIRED FOR HEMATOPOIETIC STEM CELL FUNCTION

EHA Library, Oxana Bereshchenko, 266251

RUNX1 EXPRESSION IN NG2+ PERIVASCULAR CELLS IS REQUIRED FOR PROPER AORTIC EMBRYONIC HAEMATOPOIETIC ACTIVITY IN VIVO

EHA Library, Zaniah Gonzalez Galofre, 266252

TRANSCRIPTOME-PROTEOME CORRELATION IN HUMAN HEMATOPOIETIC STEM AND PROGENITOR CELLS

EHA Library, Fabienne Meier-Abt, 266253

DENSE TEMPORAL PROFILING OF EPIGENETIC EVENTS REVEALS TWO DISCRETE PROGRAMS THAT GOVERN HUMAN ERYTHROPOIESIS

EHA Library, Grigorios Georgolopoulos, 266254

HETEROGENEITY IN EPIGENETICALLY REGULATED LIN28A-LET-7A-5P-ROS AXIS LEADS TO HETEROGENEITY IN MEGAKARYOCYTE MATURATION

EHA Library, Kazuya Hashimoto, 266255

BETA-CATENIN/TCF SIGNALING PATHWAY PROMOTES GRANULOCYTIC DIFFERENTIATION OF HEMATOPOIETIC PROGENITORS BY FACILITATING IL-1 RECEPTOR SIGNALING

EHA Library, Petr Daněk, 266256

MECHANISM OF MORPHOLOGICAL REMODELING OF BONE MARROW ADIPOCYTES IN ACUTE MYELOID LEUKEMIA

EHA Library, Shaoxin Yang, 266257

THIOPURINE-MEDIATED IMPAIRMENT OF HEMATOPOIEIC STEM AND PROGENITOR CELLS IN NUDT15R138C KNOCK-IN MICE AND POTENTIALITY OF NUDT15 GENOTYPE-BASED PRECISION MEDICINE FOR ACUTE LEUKEMIA

EHA Library, Goichi Tatsumi, 266258

ANGELICA SINENSIS POLYSACCHARIDE MAINTAINS THE FUNCTION OF HEMATOPOIETIC STEM CELLS BY REGULATING THE TREG/TH17 RATIO AND THEREBY INDUCES ANTI-MITOCHONDRIAL APOPTOSIS IN APLASTIC ANEMIA

EHA Library, Xing Cui, 266259

SINGLE CELL RNASEQ REVEALS THE IN VIVO DIFFERENTIATION POTENTIAL AND TRANSCRIPTIONAL DYNAMICS OF IMMATURE HUMAN THYMOCYTES.

EHA Library, Marieke Lavaert, 266260

DISTINCT CONTRIBUTIONS OF KAT2A HISTONE ACETYL-TRANSFERASE COMPLEXES TO HUMAN ERYTHROPOIESIS

EHA Library, Liliana Arede, 266261

SPECIAL AT-RICH SEQUENCE BINDING PROTEIN 1 (SATB1) IS MARKEDLY EXPRESSED IN THE DARK ZONE GERMINAL CENTER B CELLS ON MURINE SPLEEN

EHA Library, Takayuki Ozawa, 266262

LARGE SCALE CULTURE AND DIFFERENTIATION OF ERYTHROBLASTS FROM PBMC

EHA Library, Marie-Jose Claessen, 266263

DEFERASIROX DRIVES ROS-MEDIATED DIFFERENTIATION AND INDUCES INTERFERON-STIMULATED GENES EXPRESSION IN HEALTHY HEMATOPOIETIC STEM/PROGENITOR CELLS AND IN LEUKEMIA CELLS

EHA Library, Tiziana Tataranni, 266264

UPREGULATION OF CD276 IN ENDOTHELIAL CELLS OF MURINE AND PDX ACUTE MYELOID LEUKAEMIA MODELS

EHA Library, Antoniana Batsivari, 266265

POTENTIAL COMBINATIONAL THERAPY OF LEUKEMIC STEM CELLS USING BONE MORPHOGENETIC PROTEIN AND TYROSINE KINASE INHIBITORS.

EHA Library, Caroline Busch, 266266

NEW MOLECULES INSPIRED ON MICROBIOTA METABOLITES TARGETING ACUTE MYELOID LEUKEMIA CELLS

EHA Library, Sergio Algar, 266267

PRIMARY THERAPY AND RELATIVE SURVIVAL IN CLASSIC HODGKIN LYMPHOMA: A NATIONWIDE POPULATION-BASED STUDY AMONG 9,367 ADULT PATIENTS DIAGNOSED IN THE NETHERLANDS FROM 1989 TO 2016

EHA Library, Julia Driessen, 266268

TISLELIZUMAB (BGB-A317) FOR RELAPSED/REFRACTORY CLASSICAL HODGKIN LYMPHOMA: UPDATED FOLLOW-UP EFFICACY AND SAFETY RESULTS FROM A PHASE 2 STUDY

EHA Library, Yuqin Song, 266269

FIVE-YEAR SURVIVAL AND DURABILITY RESULTS OF THE BEGEV REGIMEN FOLLOWED BY AUTOLOGOUS STEM CELL TRANSPLANTATION (ASCT) FOR RELAPSED/REFRACTORY CLASSICAL HODGKIN LYMPHOMA

EHA Library, Francesca RICCI, 266270

DEPRESSION AND ANXIETY IN HODGKIN LYMPHOMA SURVIVORS: A DANISH NATIONWIDE COHORT STUDY OF 896 PATIENTS

EHA Library, Andreas Øvlisen, 266271

VERY LATE REALAPSES (VLR) ≥5 YEARS AFTER INITIAL TREATMENT WITH CHEMOTHERAPY±RADIOTHERAPY (CT±RT) IN HODGKIN LYMPHOMA (HL): A JOIN STUDY ON TREATMENT STRATEGIES AND PROGNOSTIC FACTORS FOR THE OUTCOME

EHA Library, Theodoros Vassilakopoulos, 266272

PEDIATRIC HODGKIN LYMPHOMA: DISPARITIES IN SURVIVAL BY RACE

EHA Library, Karishma Khullar, 266273

RETROSPECTIVE REAL-LIFE STUDY OF BRENTUXIMAB VEDOTIN IN ASSOCIATION WITH BENDAMUSTINE IN REFRACTORY OR MULTIPLE RELAPSED HODGKIN LYMPHOMA.

EHA Library, Emilio iannitto, 266274

PROGNOSTIC VALUE OF METABOLIC TUMOR VOLUME AND TOTAL LESION GLYCOLYSIS CALCULATION ON BASELINE 18F-FDG-PET-CT IN PATIENTS WITH HODGKIN´S LYMPHOMA AND ITS CORRELATION WITH CLINICAL CHARACTERISTICS

EHA Library, Karla Bermúdez, 266275

SALVAGE OPTIONS FOR HD PATIENTS FAILING INITIAL ABVD TREATMENT

EHA Library, Oliver Karanfilski, 266276

CHANGES IN OVERALL SURVIVAL OF HODGKIN’S LYMPHOMA PATIENTS IN UKRAINIAN POPULATION DURING LAST DECADES

EHA Library, Kateryna Filonenko, 266277

DOES ESCALATED BEACOP-DACARBAZINE DO THE SAME AS ESCALATED BEACOP-PROCARBAZINE FOR UNFAVORABLE HODGKIN’S LYMPHOMA?

EHA Library, Raoudha Mansouri, 266278

CLINICAL AND BIOLOGICAL PREDICTORS OF OUTCOME IN LARGE GRANULAR LYMPHOCYTE LEUKEMIA: A SINGLE CENTER EXPERIENCE OF 205 PATIENTS.

EHA Library, Gregorio Barila', 266279

THE DUAL SYK/JAK INHIBITOR CERDULATINIB DEMONSTRATES RAPID AND DURABLE TUMOR RESPONSES IN A PHASE 2 STUDY IN RELAPSED/REFRACTORY FOLLICULAR LYMPHOMA - AS A SINGLE AGENT AND COMBINED WITH RITUXIMAB

EHA Library, Paul A. Hamlin, 266280

UPDATED SAFETY AND EFFICACY DATA IN A PHASE 1/2 TRIAL OF PATIENTS WITH WALDENSTRÖM MACROGLOBULINAEMIA (WM) TREATED WITH THE BRUTON TYROSINE KINASE (BTK) INHIBITOR ZANUBRUTINIB (BGB-3111)

EHA Library, Judith Trotman, 266281

CLINICAL EFFICACY OF THE RIBVD REGIMEN FOR REFRACTORY/RELAPSED (R/R) MANTLE CELL LYMPHOMA (MCL) PATIENTS: A RETROSPECTIVE STUDY OF THE LYSA GROUP.

EHA Library, Caroline Regny, 266282

EFFICACY WAS IMPROVED WITH LENALIDOMIDE/RITUXIMAB (R2) VS RITUXIMAB/PLACEBO IN PATIENTS WITH FOLLICULAR LYMPHOMA IRRESPECTIVE OF POD24 STATUS IN THE PHASE III AUGMENT STUDY

EHA Library, John Leonard, 266283

MARKERS ASSOCIATED WITH SHORT SURVIVAL IN PATIENTS WITH WALDENSTRÖM MACROGLOBULINEMIA

EHA Library, Gordon Ruan, 266284

PARTIAL RESPONSE OR BETTER AT 6 MONTHS IS PROGNOSTIC OF PROGRESSION-FREE SURVIVAL IN PATIENTS WITH WALDENSTROM MACROGLOBULINEMIA TREATED WITH IBRUTINIB

EHA Library, Jorge Castillo, 266285

THE IMPACT OF PRIOR MALIGNANCIES ON THE DEVELOPMENT OF SECOND MALIGNANCIES AND SURVIVAL IN PATIENTS WITH FOLLICULAR LYMPHOMA: A NATIONWIDE POPULATION-BASED STUDY IN THE NETHERLANDS

EHA Library, Manette Dinnessen, 266286

MAJOR RESPONSES IN MYD88 WILDTYPE (MYD88WT) WALDENSTRÖM MACROGLOBULINEMIA (WM) PATIENTS TREATED WITH BRUTON TYROSINE KINASE (BTK) INHIBITOR ZANUBRUTINIB (BGB-3111)

EHA Library, Meletios Dimopoulos, 266287

AUTOLOGOUS STEM CELL TRANSPLANTATION FOR MANTLE CELL LYMPHOMA - OUTCOMES FROM A SINGLE ACADEMIC CENTRE

EHA Library, Michael Northend, 266288

BR VS RCHOP AS INITIAL TREATMENT FOR ADVANCED STAGE FOLLICULAR LYMPHOMA: A MATCHED-PAIR ANALYSIS

EHA Library, Paolo Strati, 266289

PRESENCE OF BRAFV600E MUTATION IN CHILDHOOD LCH CORRELATES WITH MULTISYSTEM DISEASE AND A POOR SURVIVAL

EHA Library, Prateek Bhatia, 266290

COLD AGGLUTININ DISEASE: A RETROSPECTIVE ANALYSIS OF 95 CASES

EHA Library, Pierre Daufresne, 266291

RESPONSE AND SURVIVAL OUTCOMES OF WALDENSTROM MACROGLOBULINEMIA PATIENTS ON IBRUTINIB THERAPY ON AND OFF CLINICAL TRIAL

EHA Library, Jorge Castillo, 266292

TP53 STATUS IN MANTLE CELL LYMPHOMA (MCL) - A 10 YEAR SINGLE CENTER EXPERIENCE

EHA Library, Ezzat Elhassadi, 266293

CLINICAL OUTCOMES WITH SINGLE-AGENT IBRUTINIB FOR RELAPSED/REFRACTORY (R/R) MANTLE CELL LYMPHOMA (MCL): INTERIM ANALYSIS (IA) OF THE BELGIAN IBRUTINIB REAL-WORLD DATA (BIRD) STUDY

EHA Library, Ann Janssens, 266294

WHIMSICAL (WALDENSTRÖM’S MACROGLOBULINEMIA STUDY INVOLVING CART-WHEEL): A GLOBAL PATIENT-DERIVED DATA REGISTRY MAPPING TREATMENT AND QUALITY OF LIFE DATA

EHA Library, Ibrahim Tohidi-Esfahani, 266295

TREATMENT PATTERNS AMONG PATIENTS WITH RELAPSED FOLLICULAR LYMPHOMA

EHA Library, Sheila R. Reddy, 266296

INFLAMMATION-DRIVEN HEME/IRON CYTOTOXICITY IN PARKINSON’S DISEASE

EHA Library, Raffaella Gozzelino, 266297

A PHASE 2, RANDOMIZED, CONTROLLED, OPEN-LABEL TRIAL OF DAILY VERSUS ALTERNATE DAY ORAL IRON IN TREATMENT OF IRON DEFICIENCY ANEMIA

EHA Library, Deepesh Lad, 266298

COMPLIANCE AND CLINICAL BENEFIT OF DEFERASIROX GRANULE FORMULATION VS DISPERSIBLE TABLETS IN PEDIATRIC PATIENTS WITH TRANSFUSIONAL IRON OVERLOAD: RESULTS FROM THE PHASE II CALYPSO STUDY

EHA Library, Ali T. Taher, 266299

A NEW FTL GENE MUTATION RESPONSIBLE FOR HYPOFERRITINEMIA WITHOUT IRON DEFICIENCY

EHA Library, Patricia Aguilar Martinez, 266300

HOMOZYGOUS I281T MUTATION IN HJV CAUSING INDOLENT JUVENILE HEMOCHROMATOSIS WITH A MIDDLE TO LATE ONSET

EHA Library, Akiyoshi Takami, 266301

A PROPOSAL OF AN ALGORITHM FOR THE DIAGNOSIS OF TYPE 1 GAUCHER DISEASE STARTING FROM HYPERFERRITINEMIA IN ADULTS

EHA Library, Giacomo Marchi, 266302

MIGRATION FLOWS, IRON DEFICIENCY AND ANAEMIA AMONG PREGNANT REFUGEES IN NORTHERN GREECE

EHA Library, DESPOINA ADAMIDOU, 266303

LONG-TERM SEQUENTIAL DEFERIPRONE AND DEFERASIROX THERAPY IN TRANSFUSION-DEPENDENT THALASSEMIA PATIENTS: A PROSPECTIVE CLINICAL TRIAL

EHA Library, Aurelio Maggio, 266304

FIRST-IN-HUMAN SINGLE- AND MULTIPLE-ASCENDING DOSE STUDY OF THE ORAL FERROPORTIN INHIBITOR VIT-2763 IN HEALTHY SUBJECTS

EHA Library, Frank Richard, 266305

EVIDENCE FOR AN ALTERNATIVE MECHANISM SUPPRESSING HEPCIDIN DURING THE RECOVERY FROM HEMORRHAGE-INDUCED ANEMIA

EHA Library, Ugo Sardo, 266306

THE HEPCIDIN-ERYTHROFERRONE AXIS AND ITS RELATIONSHIP WITH ERYTHROPOIESIS IN DIFFERENT TYPES OF ANEMIA

EHA Library, Rafael Del Orbe Barreto, 266307

AUTOCHTHONOUS MOUSE MODELS OF MYD88 P.L265P - AND BCL2-DRIVEN DIFFUSE LARGE B CELL LYMPHOMA

EHA Library, Ruth Fluemann, 266308

MOLECULAR ANALYSIS OF PRIMARY CUTANEOUS DIFFUSE LARGE B-CELL LYMPHOMA LEG TYPE AT DIAGNOSIS AND RELAPSE - IMPLICATIONS FOR TARGETED THERAPIES

EHA Library, Anne Schrader, 266309

A 14-GENE SIGNATURE ASSOCIATED TO CHOLESTEROL METABOLISM IDENTIFIES M1-LIKE TUMOR-INFILTRATING MACROPHAGES AND PREDICTS PATIENT SURVIVAL IN DIFFUSE LARGE B CELL LYMPHOMA

EHA Library, Maria Carmela Vegliante, 266310

DISSECTING THE MOLECULAR PROFILES IN DIFFUSE LARGE B-CELL LYMPHOMA USING THE RNA- AND PROTEIN-BARCODED NCOUNTER METHOD

EHA Library, Chih-Cheng Chen, 266311

NEXT-GENERATION SEQUENCING-BASED CLONALITY ASSESSMENT OF IMMUNOGLOBULIN GENE REARRANGEMENTS DISTINGUISHES RELAPSE FROM SECOND PRIMARY CLASSICAL HODGKIN LYMPHOMA

EHA Library, Blanca Scheijen, 266312

MUTATIONS AFFECTING THE CREBBP HAT DOMAIN PREDICT RESPONSE TO MTOR INHIBITORS EVEROLIMUS AND TEMSIROLIMUS IN RELAPSED/REFRACTORY FOLLICULAR LYMPHOMA.

EHA Library, Emil Kumar, 266313

LOSS OF 18Q22.1-Q23 IS SIGNIFICANTLY ASSOCIATED WITH GCB-DLBCL AND FAILURE TO ACHIEVE EFS24

EHA Library, Kerstin Wenzl, 266314

A PHASE I STUDY OF THE BTK INHIBITOR ABIVERTINIB (AC0010) IN PATIENTS WITH RELAPSED OR REFRACTORY B-CELL LYMPHOMA

EHA Library, Min Yang, 266315

ESTROGEN BETA RECEPTOR: A NEW TARGET FOR DIFFUSE LARGE B-CELL LYMPHOMA.

EHA Library, Myra Langendonk, 266316

SOMATIC COPY NUMBER GAINS IN MYC, BCL2, OR BCL6, IN ADDITION TO TRANSLOCATIONS, IDENTIFIES A SUBSET OF AGGRESSIVE ALTERNATIVE-DH/TH DLBCL PATIENTS

EHA Library, Jordan Krull, 266318

MOLECULAR PROFILING OF PRIMARY BONE LYMPHOMA’S REVEALS FREQUENT MUTATIONS IN EZH2 AND OTHER EPIGENETIC GENES: IMPLICATIONS FOR TARGETED TREATMENT.

EHA Library, Ruben de Groen, 266319

C-REL NF-KAPPA B SUBUNIT ACTIVITY REFINES A DISTINCT GERMINAL CENTER DIFFUSE LARGE B-CELL LYMPHOMA SUBGROUP WITH FAVORABLE OUTCOME

EHA Library, Nathalie Faumont, 266320

CHOP TREATMENT ENHANCES DEPENDENCY ON BCL-2, MCL-1 AND BCL-XL IN DIFFUSE LARGE B-CELL LYMPHOMA

EHA Library, Mathilde de Jong, 266321

MUTATIONAL LANDSCAPE OF PRIMARY MEDIASTINAL B-CELL LYMPHOMA (PMBCL) BY MEANS OF CIRCULATING TUMOR DNA ANALYSIS

EHA Library, Alfredo Rivas-Delgado, 266322

NOVEL THIENOPYRIDINE DERIVATIVES INDUCE TUBULIN DISRUPTION AND CAUSE CELL CYCLE ARREST IN MALIGNANT B-CELLS

EHA Library, Christopher Broughton, 266323

EVALUATION OF SERINE BIOSYNTHESIS PATHWAY AS A POTENTIAL THERAPEUTIC TARGET IN BURKITT LYMPHOMA

EHA Library, Emilia Bialopiotrowicz, 266324

SURVIVAL CONTINUES TO INCREASE IN DIFFUSE LARGE B-CELL LYMPHOMA: A POPULATION-BASED ANALYSIS AMONG 25,143 PATIENTS DIAGNOSED IN THE NETHERLANDS BETWEEN 1989 AND 2016

EHA Library, Mujde Durmaz, 266325

STRUCTURAL AND FUNCTIONAL VARIABILITY OF THE TUMOR B-CELL RECEPTOR INDICATES A ROLE FOR ENVIRONMENTAL INFLUENCES ON BEHAVIOR OF MANTLE CELL LYMPHOMAS

EHA Library, David Dutton, 266326